These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 91600

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors.
    Glass WF, Moore JB.
    Biochem Pharmacol; 1979 Apr 01; 28(7):1107-12. PubMed ID: 87197
    [No Abstract] [Full Text] [Related]

  • 3. Selective inhibitors of specific phosphodiesterases in intact adipocytes.
    Manganiello V, Degerman E, Elks M.
    Methods Enzymol; 1988 Apr 01; 159():504-20. PubMed ID: 2457789
    [No Abstract] [Full Text] [Related]

  • 4. Cyclic AMP phosphodiesterase activity in fetal and adult muscle of the rhesus monkey.
    Bocek RM, Beatty CH.
    Dev Biol; 1976 Feb 01; 48(2):382-91. PubMed ID: 176071
    [No Abstract] [Full Text] [Related]

  • 5. Morphone abstinence and quasi-abstinence effects after phosphodiesterase inhibitors and naloxone.
    Francis DL, Roy AC, Collier HO.
    Life Sci; 1975 Jun 15; 16(12):1901-6. PubMed ID: 168452
    [No Abstract] [Full Text] [Related]

  • 6. Differential effects of two phosphodiesterase inhibitors on fat cell metabolism.
    Shechter Y.
    Endocrinology; 1984 Nov 15; 115(5):1787-91. PubMed ID: 6208014
    [Abstract] [Full Text] [Related]

  • 7. Effects of inhibitors of cyclic nucleotide phosphodiesterase on actions of cholecystokinin, bombesin, and carbachol on pancreatic acini.
    Gardner JD, Sutliff VE, Walker MD, Jensen RT.
    Am J Physiol; 1983 Nov 15; 245(5 Pt 1):G676-80. PubMed ID: 6195928
    [Abstract] [Full Text] [Related]

  • 8. Phosphodiesterase inhibitors as tools in cyclic nucleotide research: a precautionary comment.
    Wells JN, Kramer GL.
    Mol Cell Endocrinol; 1981 Jul 15; 23(1):1-9. PubMed ID: 6167475
    [No Abstract] [Full Text] [Related]

  • 9. Effects of inhibitors of cyclic nucleotide phosphodiesterase on the actions of vasoactive intestinal peptide and secretin on pancreatic acini.
    Gardner JD, Korman LY, Walker MD, Sutliff VE.
    Am J Physiol; 1982 Jun 15; 242(6):G547-51. PubMed ID: 6178297
    [Abstract] [Full Text] [Related]

  • 10. Effect of sodium butyrate in combination with prostaglandin E1 and inhibitors of cyclic nucleotide phosphodiesterase on human amelanotic melanoma cells in culture.
    Prasad KN, Sakamoto A.
    Experientia; 1978 Dec 15; 34(12):1575-6. PubMed ID: 215447
    [Abstract] [Full Text] [Related]

  • 11. Diazepam and rolipram differentially inhibit cyclic AMP-specific phosphodiesterases PDE4A1 and PDE4B3 in the mouse.
    Cherry JA, Thompson BE, Pho V.
    Biochim Biophys Acta; 2001 Mar 19; 1518(1-2):27-35. PubMed ID: 11267656
    [Abstract] [Full Text] [Related]

  • 12. Phosphodiesterase inhibitors: their comparative effectiveness in vitro in various organs.
    Adachi K, Numano F.
    Jpn J Pharmacol; 1977 Feb 19; 27(1):97-103. PubMed ID: 194077
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the relationship between pharmacological inhibition of cyclic nucleotide phosphodiesterase and relaxation of canine tracheal smooth muscle.
    Polson JB, Krzanowski JJ, Anderson WH, Fitzpatrick DF, Hwang DP, Szentivanyi A.
    Biochem Pharmacol; 1979 Apr 15; 28(8):1391-5. PubMed ID: 87201
    [No Abstract] [Full Text] [Related]

  • 14. Differences and similarities between guanosine 3',5'-cyclic monophosphate phosphodiesterase and adenosine 3',5'-cyclic monophosphate phosphodiesterase activities in neuroblastoma cells in culture.
    Prasad KN, Becker G, Tripathy K.
    Proc Soc Exp Biol Med; 1975 Jul 15; 149(3):757-62. PubMed ID: 167381
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anagrelide: a potent and selective inhibitor of platelet cyclic AMP phosphodiesterase enzyme activity.
    Gillespie E.
    Biochem Pharmacol; 1988 Jul 15; 37(14):2866-8. PubMed ID: 2456068
    [No Abstract] [Full Text] [Related]

  • 20. The involvement of a calmodulin-dependent phosphodiesterase in the negative control of carbamylcholine on cyclic AMP levels in dog thyroid slices.
    Miot F, Dumont JE, Erneux C.
    FEBS Lett; 1983 Jan 24; 151(2):273-6. PubMed ID: 6187601
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.